Synopsys, Inc. , a world leader in software and IP for semiconductor design and manufacturing, today announced a joint collaboration with Powerchip and Nikon to deploy the Nikon Scanner Signature Files as a means to increase Proteus ProGen model accuracy on 42-nanometer flash memory designs.
BioNanomatrix, Inc., a developer of breakthrough whole genome imaging and analysis platforms for biomedical research, molecular diagnostics and personalized medicine, today announced that its low-cost nanofluidic genome analysis technology, along with founder and chief scientific officer Han Cao, has been included in Technology Review magazine?s 2009 list of 10 emerging technologies that will change the way we live and do business.
SEMATECH, a global consortium of chipmakers, announced today that it has signed a Letter of Intent with Tokyo Ohka Kogyo Co., Ltd., a leading manufacturer of photoresists, establishing the groundwork for a joint development agreement on collaborative efforts to optimize and develop new advanced imaging materials for extreme ultraviolet lithography.
A new photodiode array (PDA) detector for the TDAmax gel permeation chromatography/size exclusion chromatography (GPC/SEC) system from Viscotek provides a powerful and flexible tool for the rapid analysis of both polymers and biological macromolecules.
The project will combine IBM's semiconductor technology research and development leadership and computer modeling expertise with Applied's semiconductor processing knowledge to develop predictive models that can help minimize process variation, reduce development cost, and improve time to market for 22nm semiconductors.
Cambridge NanoTech today announced that its founder and CEO, Dr. Jill S. Becker, is being honored by Mass High Tech at their Women to Watch gala on Thursday, March 12, 2009 at the Charles Hotel in Boston, MA.
Pioneer Surgical Technology, Inc., a leading innovator in the design and manufacture of spinal and orthopaedic implants, instruments and biologic products, announced that it has won the prestigious Frost + Sullivan 2009 North American Technology Innovation of the Year Award for the E-Matrix Tissue Scaffold.
Shackleton Ventures Limited, the secondaries venture capital firm, today announces that it has completed a follow-on investment in one of its portfolio companies, NanoSight Limited, with the purchase of a significant shareholding from the National Endowment for Science, Technology and Arts (NESTA) for an undisclosed amount.